I currently serve as the Executive Director of Kidney Transplantation at AdventHealth Transplant, Porter Adventist Hospital in Denver, Colorado. I completed both my undergraduate and medical school training at Washington University in St. Louis, followed by residency training in Internal Medicine at University of California San Francisco, and completed my nephrology and transplant nephrology fellowships at University of Colorado. Prior to my current position at AdventHealth, I was a faculty member at the University of Colorado as Professor of Medicine and the Medical Director of the Kidney and Pancreas transplant programs. I have a particular interest in education and clinical leadership, and have directed numerous research, clinical, and educational programs for the AST.
Within AST, I have been privileged to serve in successive leadership roles, first as co‑chair and then chair (2007–2009) of the Kidney Pancreas Committee (the predecessor to the current KPCOP), and helped define training and accreditation standards through the ASN/AST Transplant Fellowship Accreditation Committee (2007–2010) while contributing to society leadership through the AST Nominations Committee (2007–2009). I have experience overseeing and strategically directing AST resources. serving on the AST Grants Executive Committee (2012–2017) including as the Chair from 2014–2017, helping steward the society’s grants portfolio and investments in research and career development. I have an enthusiasm for education, career development, and mentorship. Two of my most enjoyable efforts in my career include my participation (2014-2024) and leadership efforts for the AST Fellows Symposium on Transplantation Medicine as Co‑Chair (2017–2021) and founding member of its Steering Committee (2019–2022), and establishing the AST Medical Director Task Force (Co-Chair, 2019–2023) and the AST Medical Director Annual Forum Meeting (Co-Chair, 2021–2024). I have gained a great deal of insight and understanding of the AST structure, finances, partnerships, and long‑term strategic needs through my service on the AST Board of Directors as councilor‑at‑large (2015–2019), on the AST/ASTS Joint Council (2016–2019), the AST Governance Committee (2019–2020), and as chair of AST Development (2023–2025).
I hope to apply these experiences with the society’s infrastructure, resources, funding mechanisms, industry and philanthropic partnerships, together with my experiences with other transplant-associated societies, to effectively lead grant support, education, advocacy, and member services in the Treasurer’s role.
Advertisements
